Cargando…
Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF
Background: Dementia with Lewy bodies (DLB) is a neurodegenerative disease where synaptic loss and reduced synaptic integrity are important neuropathological substrates. Neuronal Pentraxin 2(NPTX2) is a synaptic protein that drives the GABAergic inhibitory circuit. Our aim was to examine if NPTX2 ce...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824459/ https://www.ncbi.nlm.nih.gov/pubmed/33383752 http://dx.doi.org/10.3390/cells10010038 |
_version_ | 1783640082231590912 |
---|---|
author | Boiten, Walter A. van Steenoven, Inger Xiao, Mei-Fang Worley, Paul F. Noli, Barbara Cocco, Cristina Ferri, Gian-Luca Lemstra, Afina W. Teunissen, Charlotte E. |
author_facet | Boiten, Walter A. van Steenoven, Inger Xiao, Mei-Fang Worley, Paul F. Noli, Barbara Cocco, Cristina Ferri, Gian-Luca Lemstra, Afina W. Teunissen, Charlotte E. |
author_sort | Boiten, Walter A. |
collection | PubMed |
description | Background: Dementia with Lewy bodies (DLB) is a neurodegenerative disease where synaptic loss and reduced synaptic integrity are important neuropathological substrates. Neuronal Pentraxin 2(NPTX2) is a synaptic protein that drives the GABAergic inhibitory circuit. Our aim was to examine if NPTX2 cerebral spinal fluid (CSF) levels in DLB patients were altered and how these levels related to other synaptic protein levels and to cognitive function and decline. Methods: NPTX2, VGF, and α-synuclein levels were determined in CSF of cognitive healthy (n = 27), DLB (n = 48), and AD (n = 20) subjects. Multiple cognitive domains were tested, and data were compared using linear models. Results: Decreased NPTX2 levels were observed in DLB (median = 474) and AD (median = 453) compared to cognitive healthy subjects (median = 773). Strong correlations between NPTX2, VGF, and α-synuclein were observed dependent on diagnosis. Combined, these markers had a high differentiating power between DLB and cognitive healthy subjects (AUC = 0.944). Clinically, NPTX2 levels related to global cognitive function and cognitive decline in the visual spatial domain. Conclusion: NPTX2 CSF levels were reduced in DLB and closely correlated to decreased VGF and α-synuclein CSF levels. CSF NPTX2 levels in DLB related to decreased functioning in the visual spatial domain. |
format | Online Article Text |
id | pubmed-7824459 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-78244592021-01-24 Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF Boiten, Walter A. van Steenoven, Inger Xiao, Mei-Fang Worley, Paul F. Noli, Barbara Cocco, Cristina Ferri, Gian-Luca Lemstra, Afina W. Teunissen, Charlotte E. Cells Article Background: Dementia with Lewy bodies (DLB) is a neurodegenerative disease where synaptic loss and reduced synaptic integrity are important neuropathological substrates. Neuronal Pentraxin 2(NPTX2) is a synaptic protein that drives the GABAergic inhibitory circuit. Our aim was to examine if NPTX2 cerebral spinal fluid (CSF) levels in DLB patients were altered and how these levels related to other synaptic protein levels and to cognitive function and decline. Methods: NPTX2, VGF, and α-synuclein levels were determined in CSF of cognitive healthy (n = 27), DLB (n = 48), and AD (n = 20) subjects. Multiple cognitive domains were tested, and data were compared using linear models. Results: Decreased NPTX2 levels were observed in DLB (median = 474) and AD (median = 453) compared to cognitive healthy subjects (median = 773). Strong correlations between NPTX2, VGF, and α-synuclein were observed dependent on diagnosis. Combined, these markers had a high differentiating power between DLB and cognitive healthy subjects (AUC = 0.944). Clinically, NPTX2 levels related to global cognitive function and cognitive decline in the visual spatial domain. Conclusion: NPTX2 CSF levels were reduced in DLB and closely correlated to decreased VGF and α-synuclein CSF levels. CSF NPTX2 levels in DLB related to decreased functioning in the visual spatial domain. MDPI 2020-12-29 /pmc/articles/PMC7824459/ /pubmed/33383752 http://dx.doi.org/10.3390/cells10010038 Text en © 2020 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Article Boiten, Walter A. van Steenoven, Inger Xiao, Mei-Fang Worley, Paul F. Noli, Barbara Cocco, Cristina Ferri, Gian-Luca Lemstra, Afina W. Teunissen, Charlotte E. Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF |
title | Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF |
title_full | Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF |
title_fullStr | Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF |
title_full_unstemmed | Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF |
title_short | Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF |
title_sort | pathologically decreased csf levels of synaptic marker nptx2 in dlb are correlated with levels of alpha-synuclein and vgf |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824459/ https://www.ncbi.nlm.nih.gov/pubmed/33383752 http://dx.doi.org/10.3390/cells10010038 |
work_keys_str_mv | AT boitenwaltera pathologicallydecreasedcsflevelsofsynapticmarkernptx2indlbarecorrelatedwithlevelsofalphasynucleinandvgf AT vansteenoveninger pathologicallydecreasedcsflevelsofsynapticmarkernptx2indlbarecorrelatedwithlevelsofalphasynucleinandvgf AT xiaomeifang pathologicallydecreasedcsflevelsofsynapticmarkernptx2indlbarecorrelatedwithlevelsofalphasynucleinandvgf AT worleypaulf pathologicallydecreasedcsflevelsofsynapticmarkernptx2indlbarecorrelatedwithlevelsofalphasynucleinandvgf AT nolibarbara pathologicallydecreasedcsflevelsofsynapticmarkernptx2indlbarecorrelatedwithlevelsofalphasynucleinandvgf AT coccocristina pathologicallydecreasedcsflevelsofsynapticmarkernptx2indlbarecorrelatedwithlevelsofalphasynucleinandvgf AT ferrigianluca pathologicallydecreasedcsflevelsofsynapticmarkernptx2indlbarecorrelatedwithlevelsofalphasynucleinandvgf AT lemstraafinaw pathologicallydecreasedcsflevelsofsynapticmarkernptx2indlbarecorrelatedwithlevelsofalphasynucleinandvgf AT teunissencharlottee pathologicallydecreasedcsflevelsofsynapticmarkernptx2indlbarecorrelatedwithlevelsofalphasynucleinandvgf |